info icon

This is a non-core endpoint: only basic statistics are computed.

Blastomycosis

AB1_BLASTOMYCOSIS

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 B40
  • Hospital discharge: ICD-9 116
  • Hospital discharge: ICD-8 116
  • Cause of death: ICD-10 B40
  • Cause of death: ICD-9 116
  • Cause of death: ICD-8 116

2 out of 7 registries used, show all original rules.

11

4. Check minimum number of events

None

11

5. Include endpoints

None

11

6. Filter based on genotype QC (FinnGen only)

11

Control definitions (FinnGen only)

Control exclude
AB1_MYCOSES

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF5

Case counts by codes

FinnGen case counts by registry codes:

Not enough data for upset plot.

Not enough data for upset table.

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 85 46 39
Only index persons 63 38 25
Unadjusted period prevalence (%)
Whole population 0.00 0.00 0.00
Only index persons 0.00 0.00 0.00
Median age at first event (years)
Whole population - 40.52 56.66
Only index persons 46.76 39.89 57.20

-FinnGen-

Key figures

All Female Male
Number of individuals 11 - 7
Unadjusted period prevalence (%) 0.00 - 0.00
Median age at first event (years) 47.88 - 67.72

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42870588) Differential panel, method unspecified - Blood
6
18
6.00
2.11
5.8
3.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
5
13
6.07
1.96
5.2
4.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
5
14
5.59
1.85
2.4
1.7
pmol/l
388.2
353.6
—
5
14
(3013512) EKG study
5
15
5.17
1.74
5.2
3.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
5
19
3.93
1.39
3.8
3.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
5
20
3.70
1.31
1.8
2.7
u/l
123.8
148.5
—
5
20
(1761868) Lipid panel - Serum or Plasma
5
21
3.48
1.24
1.6
3.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
6
29
3.31
1.12
3.5
4.9
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
6
32
2.90
1.01
7.2
3.0
e9/l
0.3
0.2
—
6
27
(3044640) Blood type and Crossmatch panel - Blood
5
24
2.95
0.88
2.0
2.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
5
28
2.42
0.77
5.0
2.3
e6/l
18.0
84.9
—
5
20
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
5
32
2.02
0.51
5.0
2.4
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
0
10
0.00
0.22
0.0
2.7
—
104.8
—
0
10
(4010399)
0
12
0.00
0.22
0.0
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
5
57
0.78
0.12
8.6
3.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
0
9
0.00
0.00
0.0
4.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(4035726)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
0
5
0.00
0.00
0.0
2.0
—
114.2
—
0
5
(3020891) Body temperature
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
0
5
0.00
0.00
0.0
2.8
—
3.6
—
0
5
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
0
5
0.00
0.00
0.0
2.8
—
1.2
—
0
5
(3005033) Fetal Nuchal fold Thickness US
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
0
5
0.00
0.00
0.0
1.8
—
0.8
—
0
5
(3000330) Specific gravity of Urine by Test strip
0
5
0.00
0.00
0.0
4.4
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
0
5
0.00
0.00
0.0
1.8
—
1.6
—
0
5
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
0
5
0.00
0.00
0.0
2.2
—
56.2
—
0
5
(3019060) Gas panel - Arterial blood
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
0
6
0.00
0.00
0.0
3.0
—
91.1
—
0
6
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
0
8
0.00
0.00
0.0
12.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
0
6
0.00
0.00
0.0
3.0
—
1.6
—
0
6
(3000492) Spirometry study
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
0
6
0.00
0.00
0.0
2.0
—
4.4
—
0
6
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
0
7
0.00
0.00
0.0
3.0
—
140.3
—
0
7
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
0
6
0.00
0.00
0.0
3.0
—
0.9
—
0
6
(3022621) pH of Urine by Test strip
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint AB1_BLASTOMYCOSIS and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have AB1_BLASTOMYCOSIS.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: AB1_BLASTOMYCOSIS – Blastomycosis

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data